DIAGNOS (OTCMKTS:DGNOF) Stock Jumps 0.1% – Still a Buy?

DIAGNOS Inc. (OTCMKTS:DGNOF – Get Free Report) shares were up 0.1% during mid-day trading on Tuesday. The stock traded as high as $0.3431 and last traded at $0.3399. Approximately 86,900 shares changed hands during trading, a decline of 19% from the average session volume of 107,312 shares. The stock had previously closed at $0.3396.

DIAGNOS Stock Up 0.1%

The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.33. The stock has a 50 day simple moving average of $0.30 and a 200 day simple moving average of $0.22. The firm has a market capitalization of $42.31 million, a PE ratio of -8.50 and a beta of -0.02.

About DIAGNOS

(Get Free Report)

DIAGNOS Inc is a Canadian healthcare technology company focused on using artificial intelligence to support the early detection and screening of diseases. The company develops and deploys computer-assisted diagnostic tools designed to help healthcare professionals analyze medical images and identify potential health conditions.

Its primary technology platform, CARA, is used for the analysis of retinal images. DIAGNOS has applied the platform to screening for eye-related conditions, including diabetic retinopathy, and has also explored applications involving other diseases and medical imaging use cases.

Further Reading

Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.